Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses

Science Immunology

Volumn 2, Issue 14, 2017, Pages

  Zhao, Jingxian ^a,b   Alshukairi, Abeer N ^c   Baharoon, Salim A ^d   Ahmed, Waleed A ^c   Bokhari, Ahmad A ^c   Nehdi, Atef M ^d   Layqah, Laila A ^d   Alghamdi, Mohammed G ^e   Al Gethamy, Manal M ^f   Dada, Ashraf M ^c   Khalid, Imran ^c   Boujelal, Mohamad ^d   Al Johani, Sameera M ^d   Vogel, Leatrice ^g   Subbarao, Kanta ^g,j   Mangalam, Ashutosh ^b   Wu, Chaorong ^h   Eyck, Patrick Ten ^h   Perlman, Stanley ^b,j   Zhao, Jincun ^a,i  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF IOWA   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^f Al Nour Specialist Hospital   (Saudi Arabia)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ GUANGZHOU MEDICAL UNIVERSITY   (China)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85047337685     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aan5393     Document Type: Article

References (30)

1. A. Zumla, D. S. Hui, S. Perlman, Middle East respiratory syndrome. Lancet 386, 995–1007 (2015).
2. S. Y. Cho, J.-M. Kang, Y. E. Ha, G. E. Park, J. Y. Lee, J.-H. Ko, J. Y. Lee, J. M. Kim, C.-I. Kang, I. J. Jo, J. G. Ryu, J. R. Choi, S. Kim, H. J. Huh, C.-S. Ki, E.-S. Kang, K. R. Peck, H.-J. Dhong, J.-H. Song, D. R. Chung, Y.-J. Kim, MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: An epidemiological outbreak study. Lancet 388, 994–1001 (2016).
3. E. I. Azhar, S. A. El-Kafrawy, S. A. Farraj, A. M. Hassan, M. S. Al-Saeed, A. M. Hashem, T. A. Madani, Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 370, 2499–2505 (2014).
4. D. L. Ng, F. Al Hosani, M. K. Keating, S. I. Gerber, T. L. Jones, M. G. Metcalfe, S. Tong, Y. Tao, N. N. Alami, L. M. Haynes, M. A. Mutei, L. Abdel-Wareth, T. M. Uyeki, D. L. Swerdlow, M. Barakat, S. R. Zaki, Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am. J. Pathol. 186, 652–658 (2016).
5. A. N. Alshukairi, I. Khalid, W. A. Ahmed, A. M. Dada, D. T. Bayumi, L. S. Malic, S. Althawadi, K. Ignacio, H. S. Alsalmi, H. M. Al-Abdely, G. Y. Wali, I. A. Qushmaq, B. M. Alraddadi, S. Perlman, Antibody response and disease severity in healthcare worker MERS survivors. Emerg. Infect. Dis. 22, 1113–1115 (2016).
6. C. Drosten, B. Meyer, M. A. Müller, V. M. Corman, M. Al-Masri, R. Hossain, H. Madani, A. Sieberg, B. J. Bosch, E. Lattwein, R. F. Alhakeem, A. M. Assiri, W. Hajomar, A. M. Albarrak, J. A. Al-Tawfiq, A. I. Zumla, Z. A. Memish, Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014).
7. D. C. Payne, I. Iblan, B. Rha, S. Alqasrawi, A. Haddadin, M. Al Nsour, T. Alsanouri, S. S. Ali, J. Harcourt, C. Miao, A. Tamin, S. I. Gerber, L. M. Haynes, M. M. Al Abdallat, Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg. Infect. Dis. 22, 1824–1826 (2016).
8. F. Tang, Y. Quan, Z.-T. Xin, J. Wrammert, M.-J. Ma, H. Lv, T.-B. Wang, H. Yang, J. H. Richardus, W. Liu, W.-C. Cao, Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study. J. Immunol. 186, 7264–7268 (2011).
9. J. Mair-Jenkins, M. Saavedra-Campos, J. K. Baillie, P. Cleary, F.-M. Khaw, W. S. Lim, S. Makki, K. D. Rooney, C. R. Beck, A. L. P. Mateus, S. Reuter, J. Shin, X. Xu, D. Pereyaslov, I. Papieva, A. Tegnell, H. Englund, Å. Elfving, R. Cox, K. G.-I. Mohn, Y. F. Jenkins, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. J. Infect. Dis. 211, 80–90 (2015).
10. V. M. Corman, A. M. Albarrak, A. S. Omrani, M. M. Albarrak, M. E. Farah, M. Almasri, D. Muth, A. Sieberg, B. Meyer, A. M. Assiri, T. Binger, K. Steinhagen, E. Lattwein, J. Al-Tawfiq, M. A. Müller, C. Drosten, Z. A. Memish, Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016).
11. J. Zhao, K. Li, C. Wohlford-Lenane, S. S. Agnihothram, C. Fett, M. J. Gale Jr., R. S. Baric, L. Enjuanes, T. Gallagher, P. B. McCray Jr., S. Perlman, Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. U.S.A. 111, 4970–4975 (2014).
12. V. S. Raj, H. Mou, S. L. Smits, D. H. W. Dekkers, M. A. Müller, R. Dijkman, D. Muth, J. A. Demmers, A. Zaki, R. A. Fouchier, V. Thiel, C. Drosten, P. J. M. Rottier, A. D. M. E. Osterhaus, B. J. Bosch, B. L. Haagmans, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254 (2013).
13. H. Chu, J. Zhou, B. H.-Y. Wong, C. Li, J. F.-W. Chan, Z.-S. Cheng, D. Yang, D. Wang, A. C.-Y. Lee, C. Li, M.-L. Yeung, J.-P. Cai, I. H.-Y. Chan, W.-K. Ho, K. K.-W. To, B.-J. Zheng, Y. Yao, C. Qin, K.-Y. Yuen, Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 213, 904–914 (2016).
14. K. V. Sheth, J. A. Edwards, J. T. Godwin, Study of the HLA gene and antigen frequency from a Saudi Arabian hospital. Tissue Antigens 25, 156–162 (1985).
15. F. F. González-Galarza, L. Y. C. Takeshita, E. J. M. Santos, F. Kempson, M. H. T. Maia, A. L. S. da Silva, A. L. Teles e Silva, G. S. Ghattaoraya, A. Alfirevic, A. R. Jones, D. Middleton, Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43, D784–D788 (2015).
16. A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. M. E. Osterhaus, R. A. M. Fouchier, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820 (2012).
17. J. Cohen, Epidemic insurance. Science 356, 125–127 (2017).
18. B. L. Haagmans, J. M. A. van den Brand, V. S. Raj, A. Volz, P. Wohlsein, S. L. Smits, D. Schipper, T. M. Bestebroer, N. Okba, R. Fux, A. Bensaid, D. S. Foz, T. Kuiken, W. Baumgartner, J. Segales, G. Sutter, A. D. M. E. Osterhaus, An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science 351, 77–81 (2016).
19. A. Liljander, B. Meyer, J. Jores, M. A. Müller, E. Lattwein, I. Njeru, B. Bett, C. Drosten, V. M. Corman, MERS-CoV antibodies in humans, Africa, 2013–2014. Emerg. Infect. Dis. 22, 1086–1089 (2016).
20. P. C. Rosato, L. K. Beura, D. Masopust, Tissue resident memory T cells and viral immunity. Curr. Opin. Virol. 22, 44–50 (2016).
21. D. R. Feikin, B. Alraddadi, M. Qutub, O. Shabouni, A. Curns, I. K. Oboho, S. M. Tomczyk, B. Wolff, J. T. Watson, T. A. Madani, Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014. Emerg. Infect. Dis. 21, 2029–2035 (2015).
22. V. M. Corman, M. A. Müller, U. Costabel, J. Timm, T. Binger, B. Meyer, P. Kreher, E. Lattwein, M. Eschbach-Bludau, A. Nitsche, T. Bleicker, O. Landt, B. Schweiger, J. F. Drexler, A. D. M. E. Osterhaus, B. L. Haagmans, U. Dittmer, F. Bonin, T. Wolff, C. Drosten, Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 17, 20334 (2012).
23. S. Koehm, R. G. Slavin, P. S. Hutcheson, T. Trejo, C. S. David, C. J. Bellone, HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis–like pulmonary responses in humanized transgenic mice. J. Allergy Clin. Immunol. 120, 570–577 (2007).
24. Y. C. Kong, L. C. Lomo, R. W. Motte, A. A. Giraldo, J. Baisch, G. Strauss, G. J. Hämmerling, C. S. David, HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: Definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 184, 1167–1172 (1996).
25. Y. Zhao, C. Wang, B. Qiu, C. Li, H. Wang, H. Jin, W. Gai, X. Zheng, T. Wang, W. Sun, F. Yan, Y. Gao, Q. Wang, J. Yan, L. Chen, S. Perlman, N. Zhong, J. Zhao, S. Yang, X. Xia, Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model. Antiviral Res. 137, 125–130 (2016).
26. J. Zhao, J. Zhao, K. Legge, S. Perlman, Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J. Clin. Invest. 121, 4921–4930 (2011).
27. C. M. Hurvich, C.-L. Tsai, Regression and time series model selection in small samples. Biometrika 76, 297–307 (1989).
28. K. P. Burnham, D. R. Anderson, Model Selection and Inference: A Practical Information-Theoretic Approach (Springer-Verlag, 1998).
29. H. Akaike, Information theory and an extension of the maximum likelihood principle, in 2nd International Symposium on Information Theory, B. N. Petrov, F. Csaki, Eds. (Springer, 1998), pp. 267–281.
30. H. Akaike, A new look at the statistical model identification. IEEE Trans. Autom. Control 19, 716–723 (1974).